Biotechnology

Thailand's Eastern Economic Corridor Promotes Genomics Project as Center of Medical Hub

BANGKOK, Aug. 6, 2020 /PRNewswire/ -- Thailand, already famed for its world class hospitals and success combating coronavirus, aims to enhance its role as a global medical hub by establishing a Thailand Genomics Sequencing Center in the country's high-tech Eastern Economic Corridor (EEC), officia...

2020-08-06 18:47 5715

Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine

NEW BRUNSWICK, New Jersey, Aug. 5, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses...

2020-08-05 20:30 6798

WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor

SHANGHAI, Aug. 4, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it was awarded as "Most Honored Company" byInstitutional Investor , an international financial publication, based on the strength o...

2020-08-04 17:00 2802

Adagio Medical, Inc., reports pre-clinical effectiveness combining their existing ultra-low temperature cryoablation catheter with Pulsed Field Ablation (PFA) in a single Pulsed Field Cryoablation (PFCA) catheter

LAGUNA HILLS, California, Aug. 4, 2020 /PRNewswire/ -- Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AFib) and ventricular tachycardia (VT), and developer of theintelligent Continuous Lesion Ablation System (iCLAS™), today announced successful pre-clinical re...

2020-08-04 10:16 2929

Macrogen Obtains Europe's CE-IVD Certificate for its COVID-19 Test Kit

SEOUL, South Korea, Aug. 4, 2020 /PRNewswire/ -- The Korean biotech company Macrogen (CEO Sukang Lee), announced on the 3rd that it had obtained the CE marking forEurope's In-Vitro Diagnostic (CE-IVD) devices for its coronavirus disease 2019 (COVID-19) test kit 'Axen™...

2020-08-04 10:00 4583

GranBio and NextChem sign partnership to develop cellulosic ethanol market

SAO PAULO and ROME, Aug. 3, 2020 /PRNewswire/ -- GranBio, a 100% Brazilian industrial biotechnology company, and NextChem, Maire Tecnimont's subsidiary for energy transition announced a strategic partnership to achieve global leadership in the licensing of patented GranBio 2G Ethanol technology t...

2020-08-03 20:54 3566

Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China

SUZHOU, China, Aug. 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...

2020-08-03 08:00 9041

INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

- INO-4800 showed durable antibody and T cell responses in rhesus macaques for 4 months - INO-4800 is the only vaccine to demonstrate long-term protection in non-human primates challenged with SARS-CoV-2 virus 13 weeks from vaccination  - Memory T and B cell responses resulted in reduced viral l...

2020-07-30 20:34 6061

Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies

Study published in Nature shows J&J's investigational SARS-CoV-2 vaccine elicits a strong immune response that protects against subsequent infection First-in-human Phase 1/2a clinical trial now underway in United States and Belgium; Phase 3 clinical trial expected to commence in September NEW BR...

2020-07-30 17:55 10433

Global X China Biotech ETF and Global X China Cloud Computing ETF Named the Most Innovative ETFs in Hong Kong by The Asset

HONG KONG, July 30, 2020 /PRNewswire/ -- Mirae Asset Global Investments (Hong Kong) Limited ("Mirae Asset") is delighted that two of its Hong Kong-listed exchange-traded funds (ETF), theGlobal X China Biotech ETF (2820.HK) and Global X China Cloud Computing ETF (2826.HK), have been recognized as ...

2020-07-30 17:15 4486

Henlius and Accord Healthcare Receive EMA Approval for Zercepac®, trastuzumab biosimilar

SHANGHAI, July 30, 2020 /PRNewswire/ -- The European Commission (EC) has approved Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord)'s Zercepac®, a biosimilar trastuzumab, for the treatment of certain patients with HER2-positive early breast cancer, HER2-positive meta...

2020-07-30 08:00 5546

Global Cord Blood Corporation Files Its Annual Report on Form 20-F

HONG KONG, July 30, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...

2020-07-30 04:16 18149

SEKISUI Diagnostics Invests £14.4 Million in cGMP Biopharma CDMO Capacity

BURLINGTON, Mass., July 29, 2020 /PRNewswire/ -- Sekisui announces the decision to invest £14.4 Million in its biopharma CDMO business aimed atcGMP microbial capacity expansion at the existing site in Maidstone, Kent to be completed by the second half of 2022. This investment follows the investme...

2020-07-29 21:00 3608

INOVIO Receives Orphan Drug Designation From U.S. FDA for DNA Medicine INO-3107 To Treat Rare Disease Recurrent Respiratory Papillomatosis (RRP)

PLYMOUTH MEETING, Pennsylvania, July 29, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO) today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for INO-3107, its DNA medicine being evaluated in a Phase 1/2 trial for treatment of recurrent respiratory papillomat...

2020-07-29 19:30 4672

BIO Asia-Taiwan 2020 Concludes Successfully

TAIPEI, July 29, 2020 /PRNewswire/ -- BIO Asia-Taiwan 2020 International Conference and Exhibition, the world's first combined onsite plus online biotechnology conference, closed onJuly 26. Held in Taipei, from July 22 to 26, the event attracted over 5,000 viewers to its online conference, of whi...

2020-07-29 17:35 2947

Celltrion Selects Movilitas for Serialization and Traceability Implementations to Ensure Supply Chain Integrity and Compliance

Project delivers a combined solution for end-to-end visibility in EU, Korea and U.S. markets COLUMBIA, Maryland, July 29, 2020 /PRNewswire/ -- Movilitas, a technology leader delivering the next generation of solutions and consulting services across multiple industries to advance smart supply cha...

2020-07-29 09:38 2741

Oscotec to Use CDD Vault to Manage Its Chemistry and Biological Research Data

The company selected the platform to help streamline its drug discovery data management process SEONGNAM-SI, South Korea and BURLINGAME, California, July 29, 2020 /PRNewswire/ -- Oscotec, a Korean biotech company engaged in the clinical stage discovery of novel drug candidates for unmet needs, a...

2020-07-29 07:00 5135

Jubilant Biosys Limited announces the merger with Jubilant Chemsys Limited

BENGALURU, India, July 28, 2020 /PRNewswire/ -- Jubilant Biosys Limited ("Biosys"), a wholly owned subsidiary of Jubilant Life Sciences Limited, today announced completion of the merger with its sister company Jubilant Chemsys Limited, based in Noida,India. The combined entities will now operate ...

2020-07-28 20:27 4844

"White Mouse in Water" - Infinitus Develops New Technology of Using Zebrafish for Health Products Screening

GUANGZHOU, China, July 28, 2020 /PRNewswire/ -- Recently, the Chinese Institute of Food Science and Technology (CIFST) brought together experts inBeijing to evaluate the results of a collaborative R&D effort between Infinitus (China) Company Ltd. and Hangzhou Hunter Biotechnology Co., Ltd., named...

2020-07-28 20:00 4632

Chengdu Hi-tech Zone Made an Increase by 7% in Industrial Added Value in the First Half of the Year

CHENGDU, China, July 28, 2020 /PRNewswire/ -- In the first half of the year, Chengdu Hi-tech Zone harvested a fruitful reward in industrial added value worth RMB119.14 billion, with a year-on-year increase of 7.0%. Chengdu Hi-tech Zone In the...

2020-07-28 16:35 4919
1 ... 160161162163164165166 ... 177